Changes in uric acid and electrolyte level in hypertensive patients attending a rural tertiary hospital in Okada Edo State
Mitsan Olley, Zekeri Sule, Emmanuel Kajoh, Goodness Sierra Leone
Corresponding author: Mitsan Olley, Department of Medical Laboratory Science, Igbinedion University, Okada, Nigeria
Received: 26 Nov 2023 - Accepted: 02 Jun 2024 - Published: 13 Sep 2024
Domain: Non-Communicable diseases epidemiology,Laboratory medicine,Obstetrics and gynecology
Keywords: Hyperuricemia, hypertension, electrolytes
©Mitsan Olley et al. PAMJ Clinical Medicine (ISSN: 2707-2797). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Mitsan Olley et al. Changes in uric acid and electrolyte level in hypertensive patients attending a rural tertiary hospital in Okada Edo State. PAMJ Clinical Medicine. 2024;16:4. [doi: 10.11604/pamj-cm.2024.16.4.42275]
Available online at: https://www.clinical-medicine.panafrican-med-journal.com//content/article/16/4/full
Research
Changes in uric acid and electrolyte level in hypertensive patients attending a rural tertiary hospital in Okada Edo State
Changes in uric acid and electrolyte level in hypertensive patients attending a rural tertiary hospital in Okada Edo State
Mitsan Olley1,&, Zekeri Sule2, Emmanuel Kajoh3, Goodness Sierra Leone1
&Corresponding author
Introduction: hypertension is a major cause of premature death worldwide. Alteration in electrolyte balance can result in hypertension, and hyperuricemia is also a potent independent predictor of hypertension. This research study was designed to investigate serum electrolytes and uric acid levels in hypertensive patients attending Igbinedion University Teaching Hospital, Okada, Edo State.
Methods: this cross-sectional study involved 105 subjects recruited into two groups: normotensive group, which served as control (n=50) with a blood pressure of about 120/80 randomly recruited on a 1:1.5 ratio with the study group which are hypertensive patients (n=55) with blood pressure above 150/110. Serum electrolytes and uric acid were estimated using the ion-selective electrode and enzymatic methods, respectively. Statisticians analyzed the data utilizing Statistical Package for Social Sciences version 21, and a p-value less than 0.05 was considered significant.
Results: this study results show a significant increase (p<0.05) in uric acid (7.4 ± 0.74), sodium (144.8 ± 4.87), bicarbonate (25.8 ± 3.00), and chloride (107.5 ± 3.98) and a significantly reduced (p<0.05) in potassium level (3.0 ± 0.35) among the hypertensive patients compared to the control subjects´ uric acid (3.7 ± 0.47), sodium (137.4 ± 2.21), bicarbonate (21.4 ± 1.73), chloride (101.2 ± 2.84), and potassium (3.9 ± 0.32).
Conclusion: the findings in this study established hyperuricemia to be more prevalent in male than in female subjects and a strong correlation between uric acid and hypertension. Likewise, hypernatremia and hyperchloremia were observed among the hypertensive subjects. Routine evaluation of uric acid levels and serum electrolytes is recommended for hypertensive patients to manage the metabolic disorders associated with hypertension and paste your abstract here.
High blood pressure represents a significant public health problem worldwide; approximately one-fourth of the adult population has hypertension. Hyperuricemia is a pathophysiological condition observed in association with chronic inflammatory diseases such as rheumatoid arthritis and cardiovascular and kidney diseases [1,2]. Similarly, the association of hyperuricemia with hypertension has long been recognized [3]. Elevated serum Uric acid is found to be associated with an increased risk of developing hypertension, diabetes, heart failure, diabetic kidney disease, and cerebrocardiovascular diseases [4-8]. Uric acid is the final product of the metabolism of purines, mainly generated from the breakdown of amino acids-rich diet, fructose, and alcohol consumption [9].
Hyperuricemia affects 25-40% of patients with untreated hypertension. However, there is a much lower prevalence in normotensives or the general population [10]. In addition to serving as an independent risk factor for incident hypertension in the general population, hyperuricemia may have significant differential effects in age, gender, and racial subgroups [11], though lower in premenopausal women compared to men in the same age bracket. Other factors that predispose to hyperuricemia include heat stress and dehydration, (which tend to promote the production of endogenous precursors), diuretics, acetylsalicylic acid, testosterone, and anti-cancer drugs [12,13]. The prevalence of hyperuricemia has been increasing in recent years, not only in advanced countries but also in developing countries [14].
Electrolytes and water are the most critical components of normal physiological function. Electrolytes are compounds that influence many aspects of body function, balance the amount of fluid inside and outside the cells throughout the body, and play a vital role in muscle contraction and heart function [15]. Without a correct balance of fluid and electrolytes, the body cells lack the electrical conductivity necessary for cellular energy production. This study is designed to evaluate Serum Electrolyte levels and uric acid and determine the correlation between uric acid and arterial blood pressure in hypertensive and normotensive patients.
Statement of the problem
Hyperuricemia is common in people who present with primary hypertension and tends to be especially common in those with accelerated (or malignant) hypertension [4]. Some of the Hyperuricemia might represent coexistent Chronic Kidney Disease (CKD) or the use of thiazide diuretics that increase serum uric acid levels. Hyperuricemia in hypertension may be due to decreased renal blood flow, microvascular diseases, and local tissue ischemia. Electrolyte imbalance affects the body and can lead to life-threatening cardiovascular conditions, including hypertension [16], which continues to be a major contributor to cardiovascular disease.
Study area
This research study was implemented in the chemical pathology laboratory of Igbinedion University Teaching Hospital, Okada, Edo State.
Study design and population
The study was a cross-sectional study involving male and female participants and categorized into:
Control group: normotensive individuals (blood pressure systolic <120 mmHg, Diastolic: < 80 mmHg), confirmed by manually checking BP using a digital set.
Study group: patients receiving antihypertensive therapy for >6 months. Fifty-five (55) hypertensive patients were recruited for this research study, Of which twenty eight (28) were males and twenty seven females). Fifty (50) normal healthy adults were recruited as control subjects (including males and females).
Blood pressure (BP) was measured in the right upper arm using a sphygmomanometer with the patient in the supine position after 10 minutes of rest. The average of two measurements was used as baseline BP for analysis, a subject was considered normotensive if Systolic Blood Pressure (SBP) was < 120 mmHg and Diastolic blood pressure (DBP) was < 80 mmHg and hypertensive if SBP ≥130 mmHg and DBP ≥ 80 mmHg. These parameters were measured irrespective of any antihypertensive group received by subjects.
Total number of patients studied were 105 (males and females). Aside from the other tests such as blood sugar and lipid profile performed, additional tests, including uric acid level and serum electrolytes, were performed in all hypertensive patients.
Selection criteria
Inclusion criteria: the inclusion criteria comprise hypertensive patients who were recently diagnosed, those on antihypertensive drugs for >6 months, and normal healthy adults who were willing and gave their informed consent to participate in the research study.
Exclusion criteria: subjects with impaired renal conditions such as Chronic Kidney Disease (CKD), those with hypertension associated with diabetic complications, rheumatoid anthritis and any viral infections were excluded.
Sample size determination
The sample size was statistically determined using the formula:
Where: n = the minimum sample size; z = the confidence interval, usually set at 1.96 and also a constant; P = the prevalence rate of hypertension 60% [17]. Q = 1- P; d = degree of accuracy desired usually set at 0.05.
The required sample size was calculated as follows:
n=[(1.96)² (0.6) (1-0.6)]/(0.05)², n =368
Since the sample size is large, the intended population size can thus be adjusted using the formula below, as described by Cochran [18].
Where no is the sample size; N = the intended population size.
n=[368/(1+(368-1)/105], n=(368×105)/368, n= 105
The researchers used one hundred and five subjects (both control and hypertensive subjects) for this study.
Sampling analysis
About seven (7) ml of venous blood was collected from the subjects into a plain container. The sample was allowed to clot and retract for about an hour, then separated using a bucket centrifuge at 3500rpm for 5 minutes. The serum was separated from cells with a Pasteur pipette and stored frozen before analysis.
Electrolyte estimation
Serum electrolytes were estimated using the ion-selective electrode method, following the manufacturer's procedure.
Principle: an Ion-Selective Electrode (ISE) makes use of the unique properties of certain membrane materials to develop an electrical potential (electromotive force, EMF) for the measurements of ions in solution. The electrode has a selective membrane in contact with both the test solution and an internal filling solution.
Uric acid
Serum uric acid will be estimated using the enzyme method.
Principle: the LX20 uses a timed endpoint method to measure the concentration of uric acid in serum, plasma, or urine. Uric acid is oxidized by uricase to produce allantoin and hydrogen peroxide. The hydrogen peroxide reacts with 4-amino antipyrine (4-AAP) and 3.5-dichloro-2-hydroxybenzene sulfonate (DCHBS) in a reaction catalyzed by peroxidase to produce a colored product. The system monitors the change in absorbance at 520 nm at a fixed time interval. The change in absorbance is directly proportional to the concentration of uric acid in the sample.
Statistical analysis
Data was imputed into an Excel spreadsheet and then exported to Statistical Package for Social Sciences version 21 for analysis and was used to compare between variables where P-value <0.05 was deemed as statistically significant at a 95% confidence interval. An unpaired T-test was used for statistical analysis because it was grouped into a hypertensive patient and a control sample.
Ethical approval and consent to participate
Approval for the research project was obtained from the ethical committee, Igbinedion University Teaching Hospital, Okada (Ref: IUTH/R.24/VOL.1/50) and preserved by authors. All participants were informed of the intent of the study in simple, understandable language.
Uric acid
Table 1 shows that 34.6% of hypertensive subjects have normal levels of uric acid, 65.4% have hyperuricemia, while control subjects have 100% normal uric acid. The uric acid level was significantly increased (p<0.05) in hypertensive subjects when compared with control. The uric acid level in hypertensive subjects was higher than the normal range.
Sodium
Table 1 show that 50.9% of hypertensive subjects have normal levels of sodium ions compared with 96% of control. Hypernatremia is high (49.1%) in hypertensive subjects compared with control (0%). None of the hypertensive subjects had hyponatremia compared with 4% of control subjects. The sodium ion level was significantly increased (p<0.05) in hypertensive subjects when compared with control. The sodium ion in control subjects falls within the normal range.
Potassium
Table 1 shows that 10.1% of hypertensive subjects have normal levels of potassium ions compared with 92% observed in the control. Hypokalemia is high (88.9%) in hypertensive subjects compared with control (8%). The potassium ion level was significantly decreased (p<0.05) in hypertensive subjects compared to control. The potassium ion in control subjects falls within the normal range.
Bicarbonate
Table 1 show that the normal level of bicarbonate in hypertensive (100%) and control (94%) was similar. When compared with control, the bicarbonate ion level was significantly increased (p<0.05) in hypertensive subjects. The bicarbonate ion in hypertensive and control subjects falls within the normal range.
Chloride
Table 1 show the normal bicarbonate level in hypertensive (76.6%) and control (98%). Almost 23.4% of hypertensive subjects are hyperchloremia compared with 0% observed in control subjects. Chloride ion level was significantly increased (p<0.05) in hypertensive subjects compared to control. The chloride ions in hypertensive and control subjects fall within the normal range.
Over sixty five of hypertensive patients were found to have elevated levels of serum uric acid (65.4%), while 49.1 percent of test subjects had hypernatremia. The prevalence of hypokalemia and hyperchloremia in hypertensive subjects were 88.9% and 23.4% respectively. All hypertensive patients had normal serum bicarbonate concentrations. A higher prevalence of uricemia was observed among hypertensive patients compared to control subjects (hypertensive vs control: 65.5% vs 0%) (Table 1 and Table 2). Our study's findings do not agree with the report from Israa, [19] whose study found an insignificant difference in uric acid level when compared with the control subjects.
The risk of developing hyperuricemia was found to be 189 times higher (OR=189.05) in hypertensive subjects compared to the control group with normal blood pressure. Being hypertensive was significantly associated with the development of hyperuricemia (P< 0.0001). Timerga et al. [20] found a significant association between hyperuricemia and hypertension. Male hypertensive patients were observed to have a higher prevalence of hyperuricemia than their female counterparts (male vs female: 75% vs 55.6%). Compared to female hypertensive patients, males are 2.4 times at a higher risk of developing hyperuricemia. However, Statistics did not show any significant difference in the prevalence of hyperuricemia concerning gender (P=0,162), this was similar to the findings of Lee et al. [21]. Age has no statistically significant influence on incidence of hyperuriceamia (P = 0.601). this association is also consistent with previous studies of [22-24]. Other identified risk factors for hyperuriceamia from other studies include smoking, abdominal obesity and increase in body mass index [23,24]. However, these risk factors were not evaluated in this study.. However, the use of specific antihypertensive drugs could affect the plasma uric acid. Drugs such as calcium channel blockers (e.g., Nifedipine) and Angiotensin 2 receptor blockers (e.g., losartan) can decrease the levels of plasma uric acid, while beta-blockers (e.g. metoprolol, atenolol), angiotensin-converting enzyme inhibitors (e.g., lisinopril, enalapril) can increase plasma uric acid concentration [22,24-26].
The highest prevalence of hyperuricemia was observed among hypertensive patients within the age group of 66-75 years, while the least was recorded among patients in the age bracket of 56-65 years. Overall, age was not found to significantly affect the prevalence of hyperuricemia in this study (P=0.601). Several studies have documented that the elevated Plasma Uric Acid (PUA) level is associated with developing essential hypertension or its complications, cardiovascular disease, and the risk factors of metabolic syndrome [21,22]. Uric acid has several reported effects by which it may play a pathogenic role in the development of hypertension [22,23]. Western/urban lifestyle, increase in age, and presence of metabolic syndromes are fingered to be responsible for elevation of PUA [24,25].
Hypernatremia was observed among 27 (49.1%) of hypertensive patients, while control subjects had a zero (0%) prevalence. Hypertensive patients were found to have a 120 times higher (OR=120.80) risk of developing hypernatremia than control subjects (Table 1), with statistics showing this risk significant (P < 0.0001). Our finding agrees with reports whose findings documented a substantial association between hypernatremia and hypertension [26,27]. Likewise, a higher prevalence of hyperchloremia was observed among male hypertensive patients than among females (male vs female: 25.0% vs. 22.2 %) (Table 1), statistics failed to show a significant difference in prevalence of hyperchloremia with respect to gender (P = 1.000). Chlorides are anions that are selectively reabsorbed with sodium in the renal tubules; the possible mechanism of hypochloremia may be similar to hyponatremia [28]. The prevalence of hyperchloremia was observed to be highest among hypertensive patients in the age group of 66-75 years, while the least was recorded among those aged 46-55 years. An insignificantly higher prevalence of hypernatremia was observed among hypertensive patients in comparison to control subjects (hypertensive vs control: 50% vs 40%; OR= 1.077; P =1.000). Hypertensive patients within the age group of 66-75 years recorded the lowest prevalence of hypernatremia. Although the highest prevalence of 68.7% was observed among those within the age group of 46-55 years, the prevalence of hypernatremia was not significantly affected by age (P=0.760). The finding has demonstrated that plasma concentrations of sodium are associated with hypertension irrespective of age and gender, as shown in Table 3 and Table 4. Prior studies have equally demonstrated that a slight increase of sodium above the reference range (140 ± 1mEq/l) may lead to hypertension [28,29].
In this study, all control subjects had a plasma chloride concentration within the normal range. This was not the same for hypertensive patients who had 13 (23.6%) (Table 1) patients expressing elevated levels of serum chloride (hyperchloremia). Hypertensive patients were found to have an 18 times higher risk of developing hyperchloremia than control subjects. Hypertension was identified as a risk factor for the development of hyperchloremia in this study (P = 0.006). This finding agrees with reports of Israa et al., Diana et al. and Testani et al. [19,30,31]. However, chlorides are selectively reabsorbed with sodium in the renal tubules, and hypochloremia may increase the likelihood of mortality [27]. All hypertensive and control subjects had no significant difference in serum bicarbonate concentration (Table 1). A total of 49 (88.1%) patients with hypertension were observed to have reduced serum potassium concentration (hypokalemia) (Table 1) as against 4 (8.0%) recorded in the control group of subjects. Hypertensive patients were forty-six times (OR=46.00) more likely to develop hypokalemia than their non-hypertensive (control) counterparts). This report agrees with the findings of Wu et al. [32]. In general, there was a statistically significant association between hypertension and development of hyperkalemia in this study (P = 0.0001).
Compared to female patients, male hypertensive patients had a lower prevalence of hypokalemia (male vs female), with a prevalence of 85.7% and 92.6%, respectively (Table 3). In general, the prevalence of hypokalemia was not significantly affected by gender (P = 0.669). All (100%) hypertensive patients within the age group of 56-65 had reduced potassium (hypokalemia). Those in the age group of 66-75 years had the lowest prevalence of 71.4%. Age was not identified as a risk factor for hypokalemia in hypertensive patients in this study (P = 0.678) (Table 4). The prevalence obtained in this study was contrary to what was obtained by Wu et al. [32], with prevalence of 6.3% but in line with the results of Lago et al. [33], with 82.8% for mild hypokalemia. The reasons for this disparity among different study groups could be attributed to the use of complexity in types of diuretic and dietary salt intake [34]. Diuretics are associated with hypokalemia, and excretion of potassium also depends on sodium intake, which is normally recommended for hypertensive individuals; this may affect plasma potassium.
Generally, age was not identified as a risk factor for the development of hyperchloremia among hypertensive patients in this study (P = 0.267) (Table 4) and was in line with data obtained from Nnadi et al. [35]. This study, however, has some limitations, as it did not take cognizance of the type of antihypertensive medications patients are subjected to, thereby hindering inferences about the end effects of such on uric acid, thereby creating a bias of the association of uric acid and hypertension.
Recommendations
The findings in this study have implications for hypertension management and necessitate the need for routine uric acid assay for all hypertensive patients. Early detection of elevated uric acid is cost-effective, especially in primary health care settings, and will reduce complications associated with high blood pressure.
This study found a significant increase in uric acid, sodium, and chloride and a reduced potassium level among the hypertensive subjects compared to the control subjects. Serum bicarbonate levels showed no significant differences between the hypertensive patients and the control subjects. Hyperuricemia was more prevalent in male subjects than female subjects and also was most prevalent in age group 66-75 among the hypertensive patients. There was a high prevalence of hypernatremia and hyperchloremia among the hypertensive subjects. Serum bicarbonate showed no significant difference between the hypertensive subjects and the control subjects.
What is known about this topic
- Uric acid is a product of purine degradation and act as an oxidant in oxidative stress; however, it is synthesized in body tissues as well as dietary intake of proteins;
- High concentrations of uric acid in plasma correlate with development of metabolic diseases;
- Management of hypertension in this rural community is poor due to the socio-economic status of individuals.
What this study adds
- Research on the causes and outcome of hypertension among individuals indicated strong correlation between plasma uric acid and hypernatremia;
- The result of this analysis indicates increased in values of plasma uric acid serves as a biomarker for the severity of hypertension;
- Early detection of elevated values in plasma uric acid will reduce complications associated with hypertension.
The authors declare that no competing interests.
OM performed the write-up, analysis of samples using the chemistry autoanalyzer, and statistical analysis. ZS conceptualized the study and was a major contributor in writing the manuscript. GS recruited subjects and performed blood pressure checks on participants. EK did the final editing of the manuscript. All authors read and approved the final manuscript.
Members of this research team sincerely appreciate staff and management of Igbinedion University Teaching Hospital, Okada, for the use of the facility.
Table 1: uric acid and electrolyte level in study subjects
Table 2: effect of hypertension on plasma uric acid concentration
Table 3: effect of gender on prevalence of hyperuricemia and electrolytes concentrates in study subjects
Table 4: effect of age on prevalence of hyperuricemia and electrolyte levels
- Johnson RJ. Finding the truth: multivariable analysis and the assassination of Abraham Lincoln. J R Coll Physicians Edinb. 2018 Jun;48(2):153-154. PubMed | Google Scholar
- Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R et al. Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout. Arthritis Care Res (Hoboken). 2019 Mar;71(3):427-434. PubMed | Google Scholar
- Borghi C, Rodriguez-Artalejo F, De Backer G, Dallongeville J, Medina J, Nuevo J et al. Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study. Int J Cardiol. 2018 Feb 15;253:167-173. PubMed | Google Scholar
- Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966 Sep 1;275(9):457-64. PubMed | Google Scholar
- Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009 Sep;32(9):1737-42. PubMed | Google Scholar
- Huang H, Huang B, Li Y, Huang Y, Li J, Yao H et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014 Jan;16(1):15-24. PubMed | Google Scholar
- Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE et al. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 Jun;42(6):1120-1128. PubMed | Google Scholar
- Dong Y, Shi H, Chen X, Fu K, Li J, Chen H et al. Serum uric acid and risk of stroke: a dose-response meta-analysis. J Clin Biochem Nutr. 2021 May;68(3):221-227. PubMed | Google Scholar
- Lanaspa MA, Ishimoto T, Li N, Cicerchi C, Orlicky DJ, Ruzycki P et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun. 2013;4:2434. PubMed | Google Scholar
- Gois PHF, Souza ERM. Pharmacotherapy for hyperuricemia in hypertensive patients. Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD008652. PubMed | Google Scholar
- Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011 Jan;63(1):102-10. PubMed | Google Scholar
- Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int. 2014 Aug;86(2):294-302. PubMed | Google Scholar
- Kuwabara M, Kanbay M, Hisatome I. Uric Acid and Hypertension Because of Arterial Stiffness. Hypertension. 2018 Sep;72(3):582-584. PubMed | Google Scholar
- Chen LY, Zhu WH, Chen ZW, Dai HL, Ren JJ, Chen JH et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B. 2007 Aug;8(8):593-8. Google Scholar
- Ganong WF. Review of Medical Physiology. 22nd Edition, McGraw-Hill Medical, New York. 2005.
- Makusidi MA, Chijioke A, Kolo PM, Liman HM, AbdulRahman MB, Sani B et al. Prevalence and pattern of hyperuricemia in a survey among inhabitants of Sokoto metropolis, north western Nigeria. Research Journal of Health Sciences. 2016 Sep 2;4(1):61-7. Google Scholar
- Ting K, Gill TK, Keen H, Tucker GR, Hill CL. Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study. Intern Med J. 2016 May;46(5):566-73. PubMed | Google Scholar
- Donkeng M, Kuaté D, Koudjou PN, Noubiap JJ, Kuiate JR. Association between hyperuricemia and glycated hemoglobin in type 2 diabetes at the District Hospital of Dschang. Pan Afr Med J. 2021 Nov 22;40:177. PubMed | Google Scholar
- Isra'a HA. Estimation of serum uric acid, urea and creatinine in essential hypertensive patients. Tikrit Medical Journal. 2010;16(1):152-8. PubMed | Google Scholar
- Timerga A, Haile K. Evaluation of uric acid disorders and associated factors in essential hypertensive patients at Wolkite University specialized hospital, Southern Ethiopia. PLoS One. 2021 Sep 10;16(9):e0256557. PubMed | Google Scholar
- Lee SW, Kim HC, Nam C, Lee HY, Ahn SV, Oh YA et al. Age-differential association between serum uric acid and incident hypertension. Hypertens Res. 2019 Mar;42(3):428-437. PubMed | Google Scholar
- Zhang W, Sun K, Yang Y, Zhang H, Hu FB, Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. Clin Chem. 2009 Nov;55(11):2026-34. PubMed | Google Scholar
- Yokokawa H, Fukuda H, Suzuki A, Fujibayashi K, Naito T, Uehara Y et al. Association Between Serum Uric Acid Levels/Hyperuricemia and Hypertension Among 85,286 Japanese Workers. J Clin Hypertens (Greenwich). 2016 Jan;18(1):53-9. PubMed | Google Scholar
- Wei F, Sun N, Cai C, Feng S, Tian J, Shi W et al. Associations between serum uric acid and the incidence of hypertension: a Chinese senior dynamic cohort study. J Transl Med. 2016 Apr 30;14(1):110. PubMed | Google Scholar
- Sharaf El Din UAA, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J Adv Res. 2017 Sep;8(5):537-548. PubMed | Google Scholar
- Ali N, Mahmood S, Islam F, Rahman S, Haque T, Islam S et al. Relationship between serum uric acid and hypertension: a cross-sectional study in Bangladeshi adults. Sci Rep. 2019 Jun 21;9(1):9061. PubMed | Google Scholar
- Bamanikar SA, Bamanikar AA, Arora A. Study of serum uric acid and creatinine in Diabetic patients and non-diabetic patients in a tertiary teaching Hospital. J Med Res. 2016; 2(1):12-15.
- Wang J, Chen RP, Lei L, Song QQ, Zhang RY, Li YB et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590-8. PubMed | Google Scholar
- Babikr WG, Elhussein AB, Abdelraheem A, Magzoub A, Mohamed H, Alasmary M. The correlation of uric acid levels with glycemic control in type II diabetic patients. Biomedical and Pharmacology Journal. 2016 Dec 22;9(3):1005-8. Google Scholar
- Viggiano J, Coutinho D, Clark-Cutaia MN, Martinez D. Effects of a high salt diet on blood pressure dipping and the implications on hypertension. Front Neurosci. 2023 Jul 3;17:1212208. PubMed | Google Scholar
- Testani JM, Hanberg JS, Arroyo JP, Brisco MA, Ter Maaten JM, Wilson FP et al. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail. 2016 Jun;18(6):660-8. PubMed | Google Scholar
- Wu CY, Hu HY, Chou YJ, Huang N, Chou YC, Li CP. High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults. Medicine (Baltimore). 2015 Nov;94(47):e2160. PubMed | Google Scholar
- Lago RM, Pencina MJ, Wang TJ, Lanier KJ, D'Agostino RB, Kannel WB et al. Interindividual variation in serum sodium and longitudinal blood pressure tracking in the Framingham Heart Study. J Hypertens. 2008 Nov;26(11):2121-5. PubMed | Google Scholar
- Suckling RJ, Swift PA, He FJ, Markandu ND, MacGregor GA. Altering plasma sodium concentration rapidly changes blood pressure during haemodialysis. Nephrol Dial Transplant. 2013 Aug;28(8):2181-6. PubMed | Google Scholar
- Nnadi HO, Awi- Waadu DG, Ama- Tariah F. Assessment of Electrolyte Levels in Hypertensive Patients in University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria. Am J Pharm Tech Res. 2015;6:1.